Goldman Sachs sets Cochlear stock target, rating Neutral
Goldman Sachs initiated coverage on Cochlear Ltd. (COH:AU) (OTC: CHEOY), a leading company in the cochlear implant market, ...
Goldman Sachs sees limited change for Synovus shares despite strong 4Q performance
Goldman Sachs reaffirmed its Neutral stance on Synovus Financial (NYSE:SNV), maintaining a $61.00 price target. According to InvestingPro data, analyst targets range from $55 to $68, with 8 analysts ...